1. Identifying a whole-brain connectome-based model in drug-naïve Parkinson's disease for predicting motor impairment
- Author
-
Jiaqi Wen, Ting Gao, Xueqin Bai, Tao Guo, Baorong Zhang, Luyan Gu, Xiaojun Xu, Xiaojun Guan, Jingjing Wu, Haoting Wu, Xiaocao Liu, Peiyu Huang, Jingwen Chen, Cheng Zhou, and Minming Zhang
- Subjects
Parkinson's disease ,Radiological and Ultrasound Technology ,business.industry ,Motor Disorders ,Brain ,Motor impairment ,Parkinson Disease ,medicine.disease ,Magnetic Resonance Imaging ,Drug-naïve ,Neurology ,medicine ,Connectome ,Humans ,Radiology, Nuclear Medicine and imaging ,Neurology (clinical) ,Anatomy ,business ,Neuroscience ,medicine.drug - Abstract
Background The functional alternation of distinct brain networks contribute to motor impairment in Parkinson’s disease (PD) remains unclear. Identifying a whole-brain connectome-based predictive model (CPM) in drug-naïve patients and verifying its predictability among drug-managed patients would be helpful to detect generalizable brain-behavior association and reflect intrinsic functional underpinning of motor impairment. Methods Resting-state functional data of 47 drug-naïve patients were enrolled to construct a predictive model by using the CPM approach, which was subsequently validated in 115 drug-managed patients. The severity of motor impairment was assessed by calculating Unified Parkinson’s Disease Rating Scale part III (UPDRS III) scores. Predictive performance was evaluated with the correlation coefficient(rtrue) and the mean squared error (MSE) between observed and predicted scores. Results A CPM for predicting individual motor impairment in drug-naïve PD was identified with significant performance (rtrue=0.845, p
- Published
- 2021